Randomized crossover study of the efficacy and safety of Calcium polystyrene sulfonate in maintenance hemodialysis patients with dialysis hyperkalemia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TTRCC-14004155

Enrollment

Unknown

Registered

2014-01-16

Start date

2014-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperkalemia

Interventions

1:Calcium polystyrene sulfonate

2:none

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years and more; 2. Hemodialysis more than three months; 3. Patient on dialysis 2-3 times a week, four hours each treatment; 4. Predialysis serum potassium = 5.5mmol/L; 5. Patient can meet the study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patient with chronic constipation; 2. Patient with severe arrhythmia; 3. Patient with ativities tumors; 4. Hypercalcemia (calcium ion concentration higher than 2.5mmol/L); 5. Pregnant woman; 6. Intestinal stenosis and peptic ulcer patient; 7. Mental and intellectual disabilities; 8. Patient do not sign the informed consent; 9. The researchers consider the patients not suitable for clinical trials.

Design outcomes

Primary

Measure	Time frame
Potassium;	—

Secondary

Measure	Time frame
serum creatinine;uric acid;calcium;blood urea nitrogen;phosphoruse;sodium;ALT;AST;albumine;CO2 binding force;parathyroid hormone;ECG;Kt/v;eGFR;blood pressure;weight;	—

Countries

China

Contacts

Public ContactWang Jing

The First Affiliated Hospital of Dalian Medical University

wj770605@sina.com+86 15940880152

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026